<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000790245">
  <TermName>Idhifa</TermName>
  <TermPronunciation>(ide-HEE-fuh)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>
      A drug used to treat adults with acute myeloid leukemia that has come back or has not gotten better with other treatment. It is used in patients whose cancer has a mutation (change) in the 
      <GeneName>IDH2</GeneName>
       gene.  It is also being studied in the treatment of other types of cancer.  Idhifa blocks the protein made by the mutated 
      <GeneName>IDH2</GeneName>
       gene.  Blocking this protein may help keep cancer cells from growing.  Idhifa is a type of enzyme inhibitor. Also called enasidenib mesylate.
    </DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000791533" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Idhifa&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000791532" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Idhifa&quot;" language="es" id="_4"/>
  <SpanishTermName>Idhifa</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>
      Medicamento que se usa para el tratamiento de adultos con leucemia mieloide aguda que volvió o no mejoró con otro tratamiento. Se usa en pacientes cuyo cáncer tiene una mutación (cambio) en el gen 
      <GeneName>IDH2</GeneName>
      . También está en estudio para el tratamiento de otros tipos de cáncer. Idhifa bloquea la proteína que se origina del gen 
      <GeneName>IDH2</GeneName>
       mutado. Bloquear esta proteína quizás ayude a evitar la multiplicación de células cancerosas. Idhifa es un tipo de inhibidor enzimático. También se llama mesilato de enasidenib.
    </DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2017-08-07</DateFirstPublished>
  <DateLastModified>2021-09-29</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000790240" url="/about-cancer/treatment/drugs/enasidenibmesylate">Enasidenib Mesylate</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
